-
EP1526867
European procedure
Extract from the Register of European Patents
EP About this file: EP1526867
| EP1526867 - ERYTHROPOIETIN IN SUBPOLYCYTHEMIC DOSES [Right-click to bookmark this link] | |||
| Former [2005/18] | USE OF ERYTHROPOIETIN | ||
| [2006/40] | Status | No opposition filed within time limit Status updated on 29.02.2008 Database last updated on 14.06.2024 | Most recent event Tooltip | 29.02.2008 | No opposition filed within time limit | published on 02.04.2008 [2008/14] | Applicant(s) | For all designated states EPOPLUS GmbH & Co. KG Feodor-Lynen-Strasse 5 30625 Hannover / DE | [2005/18] | Inventor(s) | 01 /
BAHLMANN, Ferdinand, Hermann Stresemannallee 15 30173 Hannover / DE | 02 /
HALLER, Hermann An der Trift 8D 30559 Hannover / DE | [2006/50] |
| Former [2005/18] | 01 /
BAHLMANN, Ferdinand, Hermann Tieckstrasse 24 30625 Hannover / DE | ||
| 02 /
HALLER, Hermann An der Trift 8D 30559 Hannover / DE | Representative(s) | Schrell, Andreas, et al Gleiss Große Schrell und Partner mbB Patentanwälte Rechtsanwälte Leitzstrasse 45 70469 Stuttgart / DE | [N/P] |
| Former [2005/18] | Schrell, Andreas, Dr., et al Gleiss Grosse Schrell & Partner Patentanwälte Rechtsanwälte Leitzstrasse 45 70469 Stuttgart / DE | Application number, filing date | 03766302.8 | 25.07.2003 | [2005/18] | WO2003EP08229 | Priority number, date | DE2002134192 | 26.07.2002 Original published format: DE 10234192 | [2005/18] | Filing language | DE | Procedural language | DE | Publication | Type: | A2 Application without search report | No.: | WO2004012759 | Date: | 12.02.2004 | Language: | DE | [2004/07] | Type: | A2 Application without search report | No.: | EP1526867 | Date: | 04.05.2005 | Language: | DE | The application published by WIPO in one of the EPO official languages on 12.02.2004 takes the place of the publication of the European patent application. | [2005/18] | Type: | B1 Patent specification | No.: | EP1526867 | Date: | 25.04.2007 | Language: | DE | [2007/17] | Search report(s) | International search report - published on: | EP | 03.06.2004 | Classification | IPC: | A61K38/18, A61P9/00, A61P17/02 | [2006/40] | CPC: |
A61K38/1866 (EP,US);
A61K38/18 (KR);
A61K38/17 (KR);
A61K38/1816 (EP,US);
A61K38/1891 (EP,US);
A61K38/193 (EP,US);
A61P11/00 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
| C-Set: |
A61K38/1816, A61K2300/00 (EP,US);
A61K38/1866, A61K2300/00 (US,EP);
A61K38/1891, A61K2300/00 (US,EP);
A61K38/193, A61K2300/00 (US,EP) |
| Former IPC [2005/18] | A61K38/18, A61P9/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/18] | Extension states | AL | 28.02.2005 | LT | 28.02.2005 | LV | 28.02.2005 | MK | 28.02.2005 | Title | German: | ERYTHROPOIETIN IN SUBPOLYCYTHÄMISCHEN DOSEN | [2007/15] | English: | ERYTHROPOIETIN IN SUBPOLYCYTHEMIC DOSES | [2006/40] | French: | ERYTHROPOIETINE A DOSES SUBPOLYCYTHEMIQUES | [2006/40] |
| Former [2005/18] | ERYTHROPOETIN ZUR STIMULATION ENDOTHELIALER VORLÄUFERZELLEN | ||
| Former [2005/18] | USE OF ERYTHROPOIETIN | ||
| Former [2005/18] | UTILISATION DE L'ERYTHROPOIETINE | Entry into regional phase | 28.02.2005 | National basic fee paid | 28.02.2005 | Designation fee(s) paid | 28.02.2005 | Examination fee paid | Examination procedure | 26.02.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 28.02.2005 | Examination requested [2005/18] | 09.02.2006 | Despatch of a communication from the examining division (Time limit: M04) | 25.02.2006 | Reply to a communication from the examining division | 27.10.2006 | Communication of intention to grant the patent | 06.03.2007 | Fee for grant paid | 06.03.2007 | Fee for publishing/printing paid | Divisional application(s) | EP07001689.4 / EP1779862 | EP10000381.3 / EP2191838 | Opposition(s) | 28.01.2008 | No opposition filed within time limit [2008/14] | Fees paid | Renewal fee | 01.08.2005 | Renewal fee patent year 03 | 31.07.2006 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO8907944 (AMERICAN NAT RED CROSS [US], et al) [Y] 28-40 * page 16, line 10 - line 15 * * page 19, line 16 - line 27 * * claim - *; | [X]US4992419 (WOOG HEINRICH [DE], et al) [X] 41-43,45 * example 7; claims 1,4 *; | [Y]WO9215323 (CREATIVE BIOMOLECULES INC [US]) [Y] 28-40 * page 3, line 5; claim - *; | [X]US5198417 (DONAHUE ROBERT E [US]) [X] 41-43 * examples 1-3; claims 1-3 *; | [XY]WO9810650 (UNIV EAST CAROLINA [US], et al) [X] 1-12,15-25,37-40,42 * page 4, column 20 - column 35; claim 16 * * page 7, line 25 - page 8, line 4 * [Y] 1-42; | [XY]US5980887 (ISNER JEFFREY M [US], et al) [X] 1-12,15-25,37-40,42 * column 3, paragraph 1; claims 7-11 * [Y] 1-42; | [X]WO0061164 (KENNETH S WARREN LAB [US]) [X] 1-12,15-25,37-40,42 * claims 1,6,7 *; | [X]WO0214356 (ALTHOFF CLAUDIA [DE], et al) [X] 1-12,15-25,37-40,42 * claims 1,42 *; | [X]US2002065214 (IAINA ADRIAN [IL], et al) [X] 1-12,15-25,37-40 * claim - *; | [PX]WO02085940 (GENODYSSEE [FR], et al) [PX] 1-12,15-25,37-40,42 * claims 28-30 *; | [PX]WO03037273 (UNIV UTAH RES FOUND [US]) [PX] 1-12,15-25,37-40,42 * claim - *; | [PX]WO03057242 (CRUCELL HOLLAND BV [NL], et al) [PX] 1-12,15-25,37-40,42 * claim - *; | [X] - BUEMI M ET AL, "Recombinant erythropoietin prevents the progression of atherosclerosis in Watanabe rabbits with hereditary hypocholesterolemia", NEPHROLOGY DIALYSIS TRANSPLANTATION, & ANNUAL CONGRESS OF THE EUROPEAN RENAL ASSOCIATION AND THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATI; GENEVA, SWITZERLAND; SEPTEMBER 21-24, 1997, (1997), vol. 12, no. 9, ISSN 0931-0509, page A190, XP009021639 [X] 1-12,15-25,37-40,42 * abstract * DOI: http://dx.doi.org/10.1093/ndt/12.1.190 | [XY] - BUEMI M ET AL, "Recombinant human erythropoietin (rHuEPO): More than just the correction of uremic anemia", JOURNAL OF NEPHROLOGY 2002 ITALY, (2002), vol. 15, no. 2, ISSN 1121-8428, pages 97 - 103, XP009021789 [X] 1-12,15-25,37-40,42 * page 99, column 1 * * page 101, column 1 * * page 101, column 2 * [Y] 1-42 | [XY] - MASUDA SEIJI ET AL, "Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production", INTERNATIONAL JOURNAL OF HEMATOLOGY, &, (199907), vol. 70, no. 1, ISSN 0925-5710, pages 1 - 6, XP009021621 [X] 1-12,15-25,37-40 * page 3, column 2, paragraph 3 - page 4, column 1, paragraph 3; figure 1 * [Y] 1-42 | [XY] - KRAUSE K ET AL, "Recombinant human erythropoietin and VEGF have equal angiogenic potency: Investigation in a novel in vitro assay of human vascular tissues", EUROPEAN HEART JOURNAL, & XXIII CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY TOGETHER WITH THE 36TH ANNUAL GENERAL MEETING O; STOCKHOLM, SWEDEN; SEPTEMBER 01-05, 2001, (200109), vol. 22, no. ABSTRACT SUPPLEMENT, ISSN 0195-668X, page 154, XP001097312 [X] 1-6 * abstract * [Y] 1-42 | [Y] - MASCHIO G, "Erythropoietin and systemic hypertension", NEPHROLOGY DIALYSIS TRANSPLANTATION, &, (1995), vol. 10, no. SUPPL. 2, ISSN 0931-0509, pages 74 - 79, XP009021640 [Y] 1-27,37-42 * abstract * | [PY] - KASHIWAGI M ET AL, "Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy.", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200211), Database accession no. PREV200300039039, XP002275413 [PY] 1-27,37-42 * abstract * | [ ] - ARCHIVES OF GYNECOLOGY AND OBSTETRICS, (200211), vol. 267, no. 1, ISSN 0932-0067, pages 54 - 56 | [Y] - CONRAD KIRK P ET AL, "Placental cytokines and the pathogenesis of preeclampsia", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1997), Database accession no. PREV199799525116, XP002275414 [Y] 1-27,37-42 * abstract * | [ ] - AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, (1997), vol. 37, no. 3, ISSN 1046-7408, pages 240 - 249 | [X] - CASES A, "Recombinant human erythropoietin treatment in chronic renal failure: Effects on hemostasis and vasculature", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (2000), Database accession no. EMB-2000364537, XP002275415 [X] 1-12,15-25,37-40,42 * abstract * | [ ] - DRUGS OF TODAY 2000 SPAIN, (2000), vol. 36, no. 8, ISSN 0025-7656, pages 541 - 556 | [X] - BRAGA J ET AL, "Maternal and perinatal implications of the use of human recombinant erythropoietin.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199605), Database accession no. NLM8677769, XP002275416 [X] 1-12,15-25,37-40,42 * abstract * | [ ] - ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. MAY 1996, (199605), vol. 75, no. 5, ISSN 0001-6349, pages 449 - 3 | [X] - ARCASOY MURAT O ET AL, "Erythropoietin (EPO) stimulates angiogenesis in vivo and promotes wound healing", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (20011116), Database accession no. PREV200200261552, XP002275417 [X] 1-12,15-25,37-40,42 * abstract * | [ ] - BLOOD, 43RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY, PART 1; ORLANDO, FLORIDA, USA; DECEMBER 07-11, 2001, (20011116), vol. 98, no. 11 Part 1, ISSN 0006-4971, pages 822a - 823a | [X] - ALVAREZ ARROYO MARIA VICTORIA ET AL, "Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (199811), Database accession no. PREV199800506855, XP002275418 [X] 41-43 * abstract * | [ ] - JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, (199811), vol. 9, no. 11, ISSN 1046-6673, pages 1998 - 2004 |